DD299431A5 - Neue 2-oxo-3,8-diaza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen - Google Patents

Neue 2-oxo-3,8-diaza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen Download PDF

Info

Publication number
DD299431A5
DD299431A5 DD90343359A DD34335990A DD299431A5 DD 299431 A5 DD299431 A5 DD 299431A5 DD 90343359 A DD90343359 A DD 90343359A DD 34335990 A DD34335990 A DD 34335990A DD 299431 A5 DD299431 A5 DD 299431A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
oxo
spiro
meaning
diaza
Prior art date
Application number
DD90343359A
Other languages
German (de)
English (en)
Inventor
Edit Toth
Jozsef Toerley
Sandor Goeroeg
Laszlo Szporny
Bela Kiss
Eva Palosi
Dora Groo
Istvan Laszlovszky
Erzsebet Lapis
Ferenc Auth
Laszlo Gaal
Original Assignee
�������@������@����������@����@��Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@������@����������@����@��Kk�� filed Critical �������@������@����������@����@��Kk��
Publication of DD299431A5 publication Critical patent/DD299431A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
DD90343359A 1989-08-10 1990-08-09 Neue 2-oxo-3,8-diaza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen DD299431A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU894094A HU204276B (en) 1989-08-10 1989-08-10 Process for producing new 1-oxa-2-oxo-4-methylen-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
DD299431A5 true DD299431A5 (de) 1992-04-16

Family

ID=10966866

Family Applications (2)

Application Number Title Priority Date Filing Date
DD90343359A DD299431A5 (de) 1989-08-10 1990-08-09 Neue 2-oxo-3,8-diaza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen
DD90343354A DD299428A5 (de) 1989-08-10 1990-08-09 Neue 2-oxo-4-methylen-8-aza-spiro[4,5]dekan-derivate und verfahren zu ihrer herstellung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD90343354A DD299428A5 (de) 1989-08-10 1990-08-09 Neue 2-oxo-4-methylen-8-aza-spiro[4,5]dekan-derivate und verfahren zu ihrer herstellung

Country Status (26)

Country Link
US (2) US5132303A (zh)
EP (2) EP0412821B1 (zh)
JP (2) JPH0383985A (zh)
KR (2) KR940000830B1 (zh)
CN (1) CN1025031C (zh)
AT (2) ATE104671T1 (zh)
AU (2) AU621238B2 (zh)
CA (2) CA2023018C (zh)
DD (2) DD299431A5 (zh)
DE (2) DE69014008T2 (zh)
DK (1) DK0413516T3 (zh)
ES (2) ES2052179T3 (zh)
FI (1) FI93456C (zh)
HK (1) HK118295A (zh)
HU (2) HU204276B (zh)
IE (1) IE902885A1 (zh)
IL (2) IL95325A (zh)
IN (1) IN170979B (zh)
IS (1) IS3612A7 (zh)
MY (1) MY107240A (zh)
NO (1) NO903511L (zh)
NZ (2) NZ234846A (zh)
PL (2) PL163899B1 (zh)
SG (1) SG59864G (zh)
YU (2) YU150489A (zh)
ZA (3) ZA906304B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3751404T2 (de) * 1986-12-17 1995-12-21 Glaxo Group Ltd Verwendung von heterocyclischen Verbindungen zur Behandlung von Bewusstseinsstörungen.
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
US5852029A (en) * 1990-04-10 1998-12-22 Israel Institute For Biological Research Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
EP0492020A1 (en) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders
GB9206989D0 (en) * 1992-03-31 1992-05-13 Glaxo Group Ltd Chemical compounds
US5756743A (en) 1996-04-10 1998-05-26 Hoechst Marion Roussel Inc. Spiro cyclopent b!indole-piperidines!
US6100256A (en) * 1996-12-02 2000-08-08 Merck Sharp & Dohme Ltd. Use of NK-1 receptors antagonists for treating schizophrenic disorders
SE9604786D0 (sv) 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
US6974825B1 (en) 1996-12-20 2005-12-13 Astrazeneca Canada Inc. Compounds with analgesic effect
SE9904675D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0101770D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101771D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101769D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101773D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
KR20030087248A (ko) * 2002-05-08 2003-11-14 (주)씨엔아이 온라인을 통한 상거래 기초항목의 설정기능을 갖는 상거래관리장치
AU2010260381B2 (en) * 2009-06-16 2013-10-24 Merck Sharp & Dohme Corp. Substituted -1,3,8-triazaspiro[4.5]decane-2,4-diones
GB201416352D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127065C (zh) * 1964-04-22
CH601304A5 (zh) * 1974-02-12 1978-07-14 Buskine Sa
BE790675A (fr) * 1971-10-29 1973-04-27 Science Union & Cie Nouveaux derives de l'oxa-1 diaza-3,8 spiro (4,5) decane
FR2615515B1 (fr) * 1987-05-22 1989-06-30 Adir Nouveaux derives du spiro 4, 5 decane, leur procede de preparation et les compositions pharmaceutiques les renfermant
HU204530B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA2023018A1 (en) 1991-02-11
KR940000830B1 (ko) 1994-02-02
CN1049349A (zh) 1991-02-20
KR910004630A (ko) 1991-03-29
DK0413516T3 (da) 1994-05-24
EP0412821B1 (en) 1994-11-09
CN1025031C (zh) 1994-06-15
CA2023018C (en) 1995-11-28
YU154090A (sh) 1992-12-21
US5132303A (en) 1992-07-21
PL163899B1 (pl) 1994-05-31
FI93456B (fi) 1994-12-30
IN170979B (zh) 1992-06-27
EP0413516B1 (en) 1994-04-20
ZA906300B (en) 1991-05-29
HU204276B (en) 1991-12-30
NZ234843A (en) 1992-03-26
DD299428A5 (de) 1992-04-16
JPH0383985A (ja) 1991-04-09
JPH0381277A (ja) 1991-04-05
CA2023015A1 (en) 1991-02-11
ZA906299B (en) 1991-06-26
DE69008275T2 (de) 1994-08-04
PL164662B1 (pl) 1994-09-30
EP0413516A3 (en) 1991-11-27
EP0413516A2 (en) 1991-02-20
FI903974A0 (fi) 1990-08-10
KR910004631A (ko) 1991-03-29
HU903233D0 (en) 1990-10-28
DE69008275D1 (de) 1994-05-26
ZA906304B (en) 1991-06-26
AU621238B2 (en) 1992-03-05
HUT59375A (en) 1992-05-28
EP0412821A3 (en) 1991-11-27
ATE104671T1 (de) 1994-05-15
ES2063923T3 (es) 1995-01-16
EP0412821A2 (en) 1991-02-13
PL291648A1 (en) 1992-06-01
AU6080490A (en) 1991-02-14
US5132309A (en) 1992-07-21
ES2052179T3 (es) 1994-07-01
SG59864G (en) 1995-09-01
AU6080390A (en) 1991-02-14
IL95325A0 (en) 1991-06-30
HUT55785A (en) 1991-06-28
IL95325A (en) 1994-06-24
DE69014008T2 (de) 1995-03-23
NO903511L (no) 1991-02-11
IS3612A7 (is) 1991-02-11
YU150489A (sh) 1992-12-21
HU206677B (en) 1992-12-28
DE69014008D1 (de) 1994-12-15
ATE113951T1 (de) 1994-11-15
NZ234846A (en) 1992-03-26
IL95324A (en) 1994-02-27
HK118295A (en) 1995-07-28
IE902885A1 (en) 1991-02-27
KR940002826B1 (ko) 1994-04-04
FI93456C (fi) 1995-04-10
NO903511D0 (no) 1990-08-09
IL95324A0 (en) 1991-06-30
AU621771B2 (en) 1992-03-19
MY107240A (en) 1995-10-31
PL286443A1 (en) 1992-01-13

Similar Documents

Publication Publication Date Title
DD299431A5 (de) Neue 2-oxo-3,8-diaza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen
AT365191B (de) Verfahren zur herstellung von neuen substituierten 1,3-dihydrospiro(isobenzofuranen) und ihren salzen
DE60209251T2 (de) Adenosine a2a receptor antagonisten
DE69819891T2 (de) Spiro chinuclidin-derivate, ihre herstellung und verwendung
DE2915318A1 (de) Cycloalkyltriazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE10130020A1 (de) Substituierte 1-Oxa-2,8-diaza-spiro[4.5]dec-2-en-derivate
EP0004952A1 (de) Spiro-(dihydrobenzofuranpiperidine und -pyrrolidine) und deren Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung für Arzneimittel
DE2437610A1 (de) Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
DD216716A5 (de) Verfahren zur herstellung von octahydrobenzo (f)chinolinen
DE69914935T2 (de) 8-azabicyclo[3.2.1]okt-2-en- und -oktanderivate
DD265627A5 (de) Verfahren zur herstellung von 1-(4-aminophenyl)-4-methyl-7,8-methylendioxy-3,4-dihydro-5h-2,3-benzodiazepin
DE69007905T2 (de) 1-Oxa-2-oxo-8-azaspiro[4,5]decan-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen daraus.
DE20116125U1 (de) Amlodipinfumarat
CH626344A5 (zh)
DE69720715T2 (de) Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel
DE69226447T2 (de) NMDA Antagonisten
DE69232484T2 (de) Hydroisochinolinderivate
DE69232473T2 (de) Amid-Analoge-Derivate von bestimmten methanoverbrückten Chinolizinen
DD299425A5 (de) Neue 4,4-disubstituierte piperidin-derivate und verfahren zu ihrer herstellung
DE3402601A1 (de) Neue pharmazeutisch aktive 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)chinolinderivate, deren herstellung und verwendung
DE68905363T2 (de) Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
DE60216776T2 (de) Neue piperidin-2,6-dion bisulfatsalze und deren verwendung für die behandlung stressbezogener gemütserkrankungen
DE1795176C3 (de) hT-substituierte 5-Aminoacetyl-5,10-dihydro-l lH-dibenzo eckige Klammer auf b,e eckige Klammer zu eckige Klammer auf 1,4 eckige Klammer zu diazepin-11one und Verfahren zu ihrer Herstellung
DE2113866A1 (de) Neue Indolderivate,Verfahren zu deren Herstellung und eine,diese Verbindungen enthaltende therapeutische Zusammensetzung
DD139842A5 (de) Verfahren zur herstellung quaternaerer ammoniumsalze von phenylpropylaminen und phenylbutylaminen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee